ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution.
about
ASP2408 and ASP2409, novel CTLA4-Ig variants with CD86-selective ligand binding activity and improved immunosuppressive potency, created by directed evolution.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
ASP2408 and ASP2409, novel CTL ...... created by directed evolution.
@en
ASP2408 and ASP2409, novel CTL ...... created by directed evolution.
@nl
type
label
ASP2408 and ASP2409, novel CTL ...... created by directed evolution.
@en
ASP2408 and ASP2409, novel CTL ...... created by directed evolution.
@nl
prefLabel
ASP2408 and ASP2409, novel CTL ...... created by directed evolution.
@en
ASP2408 and ASP2409, novel CTL ...... created by directed evolution.
@nl
P2093
P2860
P356
P1476
ASP2408 and ASP2409, novel CTL ...... created by directed evolution
@en
P2093
Brent R Larsen
Bruce H Devens
Clifford Wong
Erik E Karrer
Francisco A Anderson
Kuoting Wu
Madan M Paidhungat
Marc Whitlow
Margaret A Reed
Qian Zhang
P2860
P304
P356
10.1093/PROTEIN/GZW002
P50
P577
2016-03-10T00:00:00Z